551-1711-00L  Translational Medicine and Bio-Entrepreneurship

SemesterAutumn Semester 2017
LecturersU. K. Genick, E. Hafen, M. Jenni
Periodicityyearly recurring course
Language of instructionEnglish
CommentNumber of participants limited to 30
The block course will only take place with a minimum of 10 participants.

The enrolment is done by the D-BIOL study administration.

AbstractThe course gives students a look at the entire drug development process from bench to bedside. ETH and UZH alumni from the pharma, biotech, medtech, digital health and venture capital industry will discuss how intellectual property, regulatory and financial aspects shape this process. Student teams will develop their own business idea and pitch it to a group of entrepreneurs and investors.
ObjectiveStudents know the basis of the drug development process, the basis of patenting and what is required to the start a life science company. The can develop a business idea and a rough financial plan and they can it to a panel of experts.